Cited by 1,733Renin-Angiotensin System StudiesEicosanoids and Hypertension PharmacologyCoagulation, Bradykinin, Polyphosphates, and Angioedema

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.

Angiotensin-converting enzyme 2 is an essential regulator of heart function

Crackower, Michael A., Sarao, Renu, Oudit, Gavin Y., Yagil, Chana, Kozieradzki, Ivona, Scanga, Sam E., Oliveira-dos-Santos, Antonio J., da Costa, Joan, Zhang, Liyong, Pei, York, Scholey, James, Ferrario, Carlos M., Manoukian, Armen S., Chappell, Mark C., Backx, Peter H., Yagil, Yoram, Penninger, Josef M.·2002·Nature

DOI 10.1038/nature00786

Open this paper in CoChat — free account

Abstract

Cardiovascular diseases are predicted to be the most common cause of death worldwide by 2020. Here we show that angiotensin-converting enzyme 2 (ace2) maps to a defined quantitative trait locus (QTL) on the X chromosome in three different rat models of hypertension. In all hypertensive rat strains, ACE2 messenger RNA and protein expression were markedly reduced, suggesting that ace2 is a candidate gene for this QTL. Targeted disruption of ACE2 in mice results in a severe cardiac contractility defect, increased angiotensin II levels, and upregulation of hypoxia-induced genes in the heart. Genetic ablation of ACE on an ACE2 mutant background completely rescues the cardiac phenotype. But disruption of ACER, a Drosophila ACE2 homologue, results in a severe defect of heart morphogenesis. These genetic data for ACE2 show that it is an essential regulator of heart function in vivo.

Integrity signals

Registry

Crossref · 10.1038/nature00786

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Self-citation
Global Burden of Cardiovascular Diseases
Yusuf, S., Reddy, S., Ôunpuu, S., & Anand, S. S. (2001) · Circulation · doi:10.1161/hc4601.099487 · Cited by 3,014
Handbook of Proteolytic Enzymes
(2004) · Elsevier eBooks · doi:10.1016/c2009-0-03628-9 · Cited by 2,623
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E. H., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,041
Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure
Garg, R. (1995) · JAMA · doi:10.1001/jama.273.18.1450 · Cited by 1,993
Essential Hypertension
Carretero, O. A., & Oparil, S. (2000) · Circulation · doi:10.1161/01.cir.101.3.329 · Cited by 1,155
The Handbook of proteolytic enzymes
Barrett, A. J., Rawlings, N. D., & Woessner, J. F. (1998) · Cited by 1,119
The Berkeley Drosophila Genome Project Gene Disruption Project: Single P-Element Insertions Mutating 25% of Vital Drosophila Genes
Spradling, A. C., Stern, D., Beaton, A., Rehm, E. J., Laverty, T., Mozden, N., Misra, S., & Rubin, G. M. (1999) · Genetics · doi:10.1093/genetics/153.1.135 · Cited by 781

Flagged first, then by citations

Show all 44 references

1 of the 44 references couldn’t be matched to a known paper.

Sorted by citations

Items 601–700 of 999

Hypertension and Diabetes: Role of the Renin-Angiotensin System
Jandeleit-Dahm, K. A. M., & Cooper, M. E. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.06.007 · Cited by 51
Angiotensin converting enzyme 2: A new important player in the regulation of glycemia
Chhabra, K. H., Chodavarapu, H., & Lazartigues, E. D. (2013) · IUBMB Life · doi:10.1002/iub.1190 · Cited by 49
Clinical Perspectives and Fundamental Aspects of Local Cardiovascular and Renal Renin-Angiotensin Systems
Mello, W. C. D., & Frohlich, E. D. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00016 · Cited by 54
Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry
Grobe, N., Weir, N. M., Leiva, O., Ong, F. S.-C., Bernstein, K. E., Schmaier, A. H., Morris, M., & Elased, K. M. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00346.2012 · Cited by 49
Pathological Ace2-to-Ace enzyme switch in the stressed heart is transcriptionally controlled by the endothelial Brg1–FoxM1 complex
Yang, J., Feng, X., Zhou, Q., Cheng, W. N., Shang, C., Han, P., Lin, C.-H., Chen, H.-S. V., Quertermous, T., & Chang, C.-P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525078113 · Cited by 50
Role of the Natriuretic Peptide System in Cardiorenal Protection
McFarlane, S. I., Winer, N., & Sowers, J. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.22.2696 · Cited by 49
Using Mice to Dissect Genetic Factors in Atherosclerosis
Allayee, H., Ghazalpour, A., & Lusis, A. J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000090886.40027.dc · Cited by 49
ANGIOTENSIN CONVERTING ENZYME 2 IN THE KIDNEY
Koı̈tka, A., Cooper, M. E., Thomas, M. C., & Tikellis, C. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04889.x · Cited by 48
Plasma ACE2 Activity is an Independent Prognostic Marker in Chagas' Disease and Equally Potent as BNP
Wang, Y., Moreira, M. D. C. V., Heringer‐Walther, S., Ebermann, L., Schultheiß, H., Wessel, N., Siems, W., & Walther, T. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.09.005 · Cited by 48
Recombinant Expression and Characterization of Human and Murine ACE2: Species‐Specific Activation of the Alternative Renin‐Angiotensin‐System
Poglitsch, M., Domenig, O., Schwager, C., Stranner, S., Peball, B., Janzek, E., Wagner, B., Jungwirth, H., Loibner, H., & Schuster, M. (2012) · International Journal of Hypertension · doi:10.1155/2012/428950 · Cited by 48
High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria
Park, S. E., Kim, W. J., Park, S. W., Park, J. W., Lee, N., Park, C., & Youn, B. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0782 · Cited by 48
Human Organoids and Organs‐on‐Chips for Addressing COVID‐19 Challenges
Wang, Y., Wang, P., & Qin, J. (2022) · Advanced Science · doi:10.1002/advs.202105187 · Cited by 48
ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition—implications for COVID-19
Moustafa, J. S. E.-S., Jackson, A., Brotman, S. M., Guan, L., Villicaña, S., Roberts, A. L., Zito, A., Bonnycastle, L. L., Erdos, M. R., Narisu, N., et al. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01136-w · Cited by 48
The Renal Microcirculation
Navar, L. G., Arendshorst, W. J., Pallone, T. L., Inscho, E. W., Imig, J. D., & Bell, P. D. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374530-9.00015-2 · Cited by 45
Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression
Zhong, J., Yu, X., Lin, Q., Li, X., Huang, X., Xiao, D., & Lin, S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707482 · Cited by 48
Downregulation of angiotensin converting enzyme II is associated with pacing‐induced sustained atrial fibrillation
Pan, C., Lin, J.-L., Lai, L., Chen, C., Huang, S. K. S., & Lin, C.-S. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.01.014 · Cited by 48
Pathophysiology of Cardiovascular Complications in COVID-19
Petrovič, V., Radenković, D., Radenković, G., Djordjevic, V., & Banach, M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.575600 · Cited by 49
How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis
Panariello, F., Cellini, L., Speciani, M., Ronchi, D. D., & Atti, A. R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.582345 · Cited by 49
Increased Expression of the Renin–Angiotensin System and Mast Cell Density But Not of Angiotensin-converting Enzyme II in Late Stages of Human Heart Failure
Batlle, M., Roig, E. S., Pérez‐Villa, F., Lario, S., Cejudo–Martín, P., García‐Pras, E., Ortiz, J., Roqué, M., Orús, J., Rigol, M., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.04.012 · Cited by 47
Aldosterone, but Not Angiotensin II, Reduces Angiotensin Converting Enzyme 2 Gene Expression Levels in Cultured Neonatal Rat Cardiomyocytes
Yamamuro, M., Yoshimura, M., Nakayama, M., Abe, K., Sumida, H., Sugiyama, S., Saito, Y., Nakao, K., Yasue, H., & Ogawa, H. (2008) · Circulation Journal · doi:10.1253/circj.72.1346 · Cited by 47
A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality
Smart, L., Fawkes, N., Goggin, P., Pennick, G., Rainsford, K. D., Charlesworth, B. R., & Shah, N. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00745-z · Cited by 48
Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID‐19
Niu, W., Wu, F., Cui, H., Cao, W., Chao, Y.-C., Wu, Z., Fan, M., & Liang, C. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/7493281 · Cited by 47
Renal cathepsin G and angiotensin II generation
Rykl, J., Thiemann, J., Kurzawski, S., Pohl, T., Gobom, J., Zidek, W., & Schlüter, H. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000242404.91332.be · Cited by 47
Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies
Pathangey, G., Fadadu, P., Hospodar, A. R., & Abbas, A. E. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00259.2020 · Cited by 48
Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin–angiotensin–aldosterone system: Antihypertensive effects and benefits beyond BP control
Ferrario, C. M. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.11.020 · Cited by 46
Self-citation
ACE2 and AT4R are present in diseased human blood vessels
Zulli, A., Burrell, L. M., Buxton, B., & Hare, D. L. (2009) · European Journal of Histochemistry · doi:10.4081/1184 · Cited by 46
ACE2 deficiency shifts energy metabolism towards glucose utilization
Bernardi, S., Tikellis, C., Candido, R., Tsorotes, D., Pickering, R. J., Bossi, F., Carretta, R., Fabris, B., Cooper, M. E., & Thomas, M. C. (2014) · Metabolism · doi:10.1016/j.metabol.2014.11.004 · Cited by 46
Cationic nanoparticles directly bind angiotensin-converting enzyme 2 and induce acute lung injury in mice
Sun, Y., Guo, F., Zou, Z., Li, C., Hong, X., Zhao, Y., Wang, C., Wang, H., Liu, H., Yang, P., et al. (2015) · Particle and Fibre Toxicology · doi:10.1186/s12989-015-0080-x · Cited by 46
Self-citation
Impact of ACE2 gene polymorphism on antihypertensive efficacy of ACE inhibitors
Chen, Y., Liu, D., Zhang, P., Zhong, J., Zhang, C. J., Wu, S., Zhang, Y. Q., Liu, G. Z., He, M., Jin, L., et al. (2016) · Journal of Human Hypertension · doi:10.1038/jhh.2016.24 · Cited by 46
SARS‐CoV‐2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors
Stilhano, R. S., Costa, A. J., Nishino, M. S., Shams, S., Bartolomeo, C. S., Breithaupt‐Faloppa, A. C., Silva, E. A., Ramirez, A. L., Prado, C. M., & Ureshino, R. P. (2020) · The FASEB Journal · doi:10.1096/fj.202001394rr · Cited by 48
Coronavirus Disease 2019 and the Cerebrovascular‐Cardiovascular Systems: What Do We Know So Far?
Larson, A. S., Savastano, L. E., Kadirvel, R., Kallmes, D. F., Hassan, A. E., & Brinjikji, W. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016793 · Cited by 46
Elevated Angiotensin 1–7/Angiotensin II Ratio Predicts Favorable Outcomes in Patients With Heart Failure
Wang, K., Basu, R., Poglitsch, M., Bakal, J. A., & Oudit, G. Y. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.006939 · Cited by 46
Self-citation
ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2
Iwanaga, N., Cooper, L. M., Rong, L., Maness, N. J., Beddingfield, B. J., Qin, Z., Crabtree, J. M., Tripp, R. A., Yang, H., Blair, R. V., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103670 · Cited by 46
ACE2 Overexpression Inhibits Angiotensin II-induced Monocyte Chemoattractant Protein-1 Expression in Macrophages
Yong-jun, G., Li, W., Wu, R., Xie, Q., & Cui, L. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.07.010 · Cited by 46
Letter to the Editor: Angiotensin-converting enzyme 2: an ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications
Abassi, Z. A., Assady, S., Khoury, E. E., & Heyman, S. N. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00215.2020 · Cited by 46
Novel ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV2Preprint
Iwanaga, N., Cooper, L. M., Rong, L., Beddingfield, B. J., Crabtree, J. M., Tripp, R. A., Qin, X., & Kolls, J. K. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.15.152157 · Cited by 45
Computational Design of 25-mer Peptide Binders of SARS-CoV‑2
Sitthiyotha, T., & Chunsrivirot, S. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c07890 · Cited by 41
Convergent evidences from human and animal studies implicate angiotensin I-converting enzyme activity in cognitive performance in schizophrenia
Gadelha, A., Vendramini, A. M., Yonamine, C. M., Nering, M. B., Berberian, A. D. A., Suiama, M. A., Oliveira, V., Lima-Landman, M. T., Breen, G. D., Bressan, R. A., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.181 · Cited by 46
Angiotensin converting enzyme 2 and diminazene
Velkoska, E., Patel, S. K., & Burrell, L. M. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000254 · Cited by 45
ACE2 activator diminazene aceturate ameliorates Alzheimer's disease-like neuropathology and rescues cognitive impairment in SAMP8 mice
Duan, R., Xiao, X., Zhang, Q.-Q., Wang, S., Gong, P., Yan, E., Jiang, T., & Zhang, Y. (2020) · Aging · doi:10.18632/aging.103544 · Cited by 44
ACE2: from protection of liver disease to propagation of COVID-19
Warner, F. J., Rajapaksha, H., Shackel, N. A., & Herath, C. B. (2020) · Clinical Science · doi:10.1042/cs20201268 · Cited by 46
The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
Coto, E., y, P. A., & Gómez, J. (2021) · European Cardiology Review · doi:10.15420/ecr.2020.30 · Cited by 44
Quantitative temporal‐spatial distribution of severe acute respiratory syndrome‐associated coronavirus (SARS‐CoV) in post‐mortem tissues
Tang, J. W.-T., To, K., Lo, A. W. I., Sung, J. J. �., Ng, H., & Chan, P. K. S. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20873 · Cited by 44
COVID-19 in patients with heart failure: the new and the old epidemic
Sisti, N., Valente, S., Mandoli, G. E., Santoro, C., Sciaccaluga, C., Franchi, F., Cameli, P., Mondillo, S., & Cameli, M. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138080 · Cited by 44
SARS-CoV-2 infection and thrombotic complications: a narrative review
Moschonas, I. C., & Tselepis, A. D. (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02374-3 · Cited by 45
Apelin Effects on Blood Pressure and RAS in DOCA-Salt-Induced Hypertensive Rats
Akçılar, R., Turgut, S., Caner, V., Akçılar, A., Ayada, C., Elmas, L., & Özcan, T. O. (2013) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2013.764889 · Cited by 44
Clinical characteristics and analysis of risk factors for disease progression of COVID-19: A retrospective Cohort Study
Lv, Z., & Lv, S. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.50654 · Cited by 44
Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms
Yalcin, H. C., Sukumaran, V., Al-Ruweidi, M. K. A. A., & Shurbaji, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136703 · Cited by 51
Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation
Turner, A. J., & Nalivaeva, N. N. (2022) · Peptides · doi:10.1016/j.peptides.2022.170766 · Cited by 46
Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failure
Ohtsuki, M., Morimoto, S., Izawa, H., Ismail, T. F., Ishibashi‐Ueda, H., Kato, Y., Horii, T., Isomura, T., Suma, H., Nomura, M., et al. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.11.057 · Cited by 44
Angiotensin II, the immune system and renal diseases: another road for RAS?
Suzuki, Y. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg223 · Cited by 44
Comparison of Cystine Determination in Mixed Leukocytes vs Polymorphonuclear Leukocytes for Diagnosis of Cystinosis and Monitoring of Cysteamine Therapy
Levtchenko, E. N., de Graaf-Hess, A., Wilmer, M. J. G., van den Heuvel, L. P., Monnens, L. A. H., & Blom, H. J. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.031872 · Cited by 44
A Place in Our Hearts for the Lowly Angiotensin 1-7 Peptide?
Reudelhuber, T. L. (2006) · Hypertension · doi:10.1161/01.hyp.0000209020.69734.73 · Cited by 44
'All In One' SARS-CoV-2 variant recognition platform: Machine learning-enabled point of care diagnostics
Beduk, D., Filho, J. I. D. O., Bedük, T., Harmancı, D., Zihnioğlu, F., Çiçek, C., Sertoz, R. Y., Arda, B., Göksel, T., Turhan, K., et al. (2022) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2022.100105 · Cited by 43
Nanomaterials Responsive to Endogenous Biomarkers for Cardiovascular Disease Theranostics
Wei, C., Jiang, Z., Li, C., Li, P., & Fu, Q. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202214655 · Cited by 43
Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review
Kole, C., Stefanou, Ε., Karvelas, N., Schizas, D., & Toutouzas, K. P. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07465-w · Cited by 58
Coronary “Microvascular Dysfunction”: Evolving Understanding of Pathophysiology, Clinical Implications, and Potential Therapeutics
Kei, C. Y., Singh, K., Dautov, R. F., Nguyen, T. H. T., Chirkov, Y. Y., & Horowitz, J. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411287 · Cited by 45
Local RAS and inflammatory factors are involved in cardiovascular hypertrophy in spontaneously hypertensive rats
LI, L., Yi-Ming, W., Li, Z.-Z., Zhao, L., Yu, Y.-S., Li, D., Xia, C.-Y., Liu, J.-G., & Su, D. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.06.009 · Cited by 43
ACE for all – a molecular perspective
Harrison, C., & Acharya, K. R. (2014) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-014-0236-8 · Cited by 43
Onset of Experimental Severe Cardiac Fibrosis Is Mediated by Overexpression of Angiotensin-Converting Enzyme 2
Masson, R., Nicklin, S. A., Craig, M. A., McBride, M., Gilday, K., Gregorevic, P., Allen, J. M., Chamberlain, J. S., Smith, G. L., Graham, D., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.122333 · Cited by 43
ACE2 and the Homolog Collectrin in the Modulation of Nitric Oxide and Oxidative Stress in Blood Pressure Homeostasis and Vascular Injury
Yang, G., Chu, P., Rump, L. C., Le, T. H., & Stegbauer, J. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6950 · Cited by 43
Angiotensin‐converting enzyme 2–Angiotensin 1‐7/1‐9 system: novel promising targets for heart failure treatment
Kittana, N. (2017) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12318 · Cited by 43
ACE2 as Drug Target of COVID-19 Virus Treatment, Simplified Updated Review
Mostafa‐Hedeab, G. (2020) · Reports of Biochemistry and Molecular Biology · doi:10.29252/rbmb.9.1.97 · Cited by 43
Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2)
Wiese, O. J., Zemlin, A. E., & Pillay, T. S. (2020) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-206954 · Cited by 47
The Impact of microRNAs in Renin–Angiotensin-System-Induced Cardiac Remodelling
Adamcová, M., Kawano, I., & Šimko, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094762 · Cited by 44
Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality
Mir, R., Mir, R., Alghamdi, M. A. A., Alsayed, B. A., Wani, J. I., Alharthi, M. H., & Alshahrani, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111098 · Cited by 45
Extracellular vesicles enclosed‐miR‐421 suppresses air pollution (PM 2.5 )‐induced cardiac dysfunction via ACE2 signalling
Wang, H., Wang, T., Rui, W., Xie, J., Xie, Y., Zhang, X., Guan, L., Li, G., Lei, Z., Schiffelers, R. M., et al. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12222 · Cited by 44
Albumin caused the increasing production of angiotensin II due to the dysregulation of ACE/ACE2 expression in HK2 cells
Liu, B., Gao, J., Li, Q., & Xu, L. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.12.015 · Cited by 43
Angiotensin-(1–7) Antagonist A-779 Attenuates the Potentiation of Bradykinin by Captopril in Rats
Maia, L. G., Ramos, M. C., Fernandes, L., de Carvalho, M. H. C., Campagnole‐Santos, M. J., & Santos, R. A. S. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200405000-00011 · Cited by 43
Angiotensin-converting enzyme as a target for the development of novel insect growth regulators
Isaac, R. E., Lamango, N. S., Ekbote, U. V., Taylor, C. A., Hurst, D., Weaver, R. J., Çarhan, A., Burnham, S., & Shirras, A. D. (2006) · Peptides · doi:10.1016/j.peptides.2006.08.029 · Cited by 43
ACE2 as a Therapeutic Target for COVID-19; Its Role in Infectious Processes and Regulation by Modulators of the RAAS System
Michaud, V., Deodhar, M., Arwood, M. J., Rihani, S. B. A., Dow, P., & Turgeon, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072096 · Cited by 42
Angiotensin‐converting enzyme 2 and the kidney
Soler, M. J., Wysocki, J. A., & BATLLE, D. C. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.041350 · Cited by 42
Fibroblast growth factor 23 modifies the pharmacological effects of angiotensin receptor blockade in experimental renal fibrosis
de Jong, M. A., Mirković, K., Mencke, R., Hoenderop, J. G. J., Bindels, R. J. M., Vervloet, M. G., Hillebrands, J., van den Born, J., Navis, G. J., & de Borst, M. H. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw105 · Cited by 42
COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?
Zorès, F., & Rebeaud, M. E. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00071 · Cited by 40
Is highly expressed ACE 2 in pregnant women “a curse” in times of COVID-19 pandemic?
Dhaundiyal, A., Kumari, P., Jawalekar, S. S., Chauhan, G., Kalra, S., & Navik, U. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118676 · Cited by 42
Six Truisms Concerning ACE and the Renin-Angiotensin System Educed From the Genetic Analysis of Mice
Bernstein, K. E., Xiao, H., Frenzel, K. E., Li, P., Shen, X. Z., Adams, J. W., & Fuchs, S. (2005) · Circulation Research · doi:10.1161/01.res.0000169536.73576.66 · Cited by 42
Effects of ACE2 Inhibition in the Post-Myocardial Infarction Heart
Kim, M., Yang, D., Kida, K., Molotkova, N., Yeo, S. J., Varki, N. M., Iwata, M., Dalton, N. D., Peterson, K. L., Siems, W., et al. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.04.002 · Cited by 42
Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2
Lisi, L., Lacal, P. M., Barbaccia, M. L., & Graziani, G. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114169 · Cited by 42
Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists
Steckelings, U. M., & Sumners, C. (2020) · Clinical Science · doi:10.1042/cs20200922 · Cited by 43
S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Nejat, R., Torshizi, M. F., & Najafi, D. J. (2023) · Vaccines · doi:10.3390/vaccines11020204 · Cited by 44
Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease
Wang, W., Patel, V. B., Parajuli, N., Dong, F., Basu, R., Wang, Z., Ramprasath, T., Kassiri, Z., Penninger, J. M., & Oudit, G. Y. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1149-y · Cited by 40
Self-citation
Angiotensin-(1–7) Mas-receptor deficiency decreases peroxisome proliferator-activated receptor gamma expression in adipocytes
Mário, É. G., Santos, S. H. S., Ferreira, A. V. M., Bäder, M., Santos, R. A. S., & Botion, L. M. (2011) · Peptides · doi:10.1016/j.peptides.2011.11.014 · Cited by 41
Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2)
Zemlin, A. E., & Wiese, O. J. (2020) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563220928361 · Cited by 40
Functional angiotensin‐converting enzyme 2 is expressed in human cardiac myofibroblasts
Guy, J. L., Lambert, D., Turner, A. J., & Porter, K. E. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.040139 · Cited by 41
An ACE structure
Hooper, N. M., & Turner, A. J. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb0303-155 · Cited by 41
Genetically altered animal models in the kallikrein-kinin system
Pesquero, J. B., & Bäder, M. (2006) · Biological Chemistry · doi:10.1515/bc.2006.017 · Cited by 41
Angiotensin II-induced inotropism requires an endocardial endothelium-nitric oxide mechanism in the in-vitro heart of Anguilla anguilla
Imbrogno, S., Cerra, M. C., & Tota, B. (2003) · Journal of Experimental Biology · doi:10.1242/jeb.00468 · Cited by 41
Does the Angiotensin-Converting Enzyme (ACE)/ACE2 Balance Contribute to the Fate of Angiotensin Peptides in Programmed Hypertension?
Brosnihan, K. B., Neves, L. A. A., & Chappell, M. C. (2005) · Hypertension · doi:10.1161/01.hyp.0000185149.56516.0a · Cited by 41
Self-citation
The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data AnalysisPreprint
Feng, Z., Li, J. S. Y., Yao, S., Yu, Q., Zhou, W., Mao, X., Li, H., Kang, W., Ouyang, X., Ji, M., et al. (2020) · medRxiv · doi:10.1101/2020.04.08.20057539 · Cited by 39
COVID‐19 breakthroughs: separating fact from fiction
Dhillon, P., Breuer, M., & Hirst, N. L. (2020) · FEBS Journal · doi:10.1111/febs.15442 · Cited by 42
The High Blood Pressure-Malaria Protection Hypothesis
Gallego‐Delgado, J., Walther, T., & Rodrı́guez, A. (2016) · Circulation Research · doi:10.1161/circresaha.116.309602 · Cited by 40
FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults
Akhabue, E., Montag, S. E., Reis, J. P., Pool, L. R., Mehta, R. C., Yancy, C. W., Zhao, L., Wolf, M. S., Gutiérrez, O. M., Carnethon, M. R., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11060 · Cited by 42
SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus
Iacob, S. A., & Iacob, D. G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01224 · Cited by 42
Thermodynamics of the Interaction between the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus‑2 and the Receptor of Human Angiotensin-Converting Enzyme 2. Effects of Possible Ligands
García‐Iriepa, C., Hognon, C., Francés‐Monerris, A., Iriepa, I., Miclot, T., Barone, G., Monari, A., & Marazzi, M. (2020) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.0c02203 · Cited by 39
Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19
Zhang, H., Shao, B., Dang, Q., Chen, Z., Zhou, Q., Luo, H., Yuan, W., & Sun, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.674074 · Cited by 39
Identifying genes that interact with Drosophila presenilin and amyloid precursor protein
van de Hoef, D. L., Hughes, J., Livne‐Bar, I., Garza, D., Konsolaki, M., & Boulianne, G. L. (2009) · genesis · doi:10.1002/dvg.20485 · Cited by 40
The emerging role of angiotensin-converting enzyme-2 in the kidney
Burns, K. D. (2007) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3280123c0e · Cited by 40
Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study
Santosa, A., Franzén, S., Nåtman, J., Wettermark, B., Parmryd, I., & Nyberg, F. (2022) · Scientific Reports · doi:10.1038/s41598-022-16357-2 · Cited by 42
The Role of Renin–Angiotensin System in Diabetic Cardiomyopathy: A Narrative Review
Batista, J. P. T., de Faria, A. O. V., Ribeiro, T. F. S., & Silva, A. C. S. E. (2023) · Life · doi:10.3390/life13071598 · Cited by 40
The Effects of Angiotensin II and Angiotensin-(1–7) in the Rostral Ventrolateral Medulla of Rats on Stress-Induced Hypertension
Du, D., Chen, J., Liu, M., Zhu, M., Jing, H., Fang, J., Shen, L., Zhu, D., Yu, J., & Wang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070976 · Cited by 39

Authors: Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., Scholey, J., Ferrario, C. M., Manoukian, A. S., Chappell, M. C., Backx, P. H., Yagil, Y., & Penninger, J. M.
Affiliations: University of Toronto (CA)
Institute of Molecular Biotechnology (AT)
University Health Network (CA)
Barzilai Medical Center (IL)
Atrium Health Wake Forest Baptist (US)
Corresponding author: Penninger, Josef M.
ORCID: Crackower, Michael A.
Oudit, Gavin Y.
Kozieradzki, Ivona
Zhang, Liyong
Pei, York
Scholey, James
Ferrario, Carlos M.
Chappell, Mark C.
Backx, Peter H.
Yagil, Yoram
Penninger, Josef M.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2002-06
Volume: 417
Issue: 6891
Pages: 822-828
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature00786
OpenAlex: W2025672718
Cited by: 1,733
References: 44
Citations by year: 2026: 12 · 2025: 25 · 2024: 38 · 2023: 88 · 2022: 117 · 2021: 215 · 2020: 311 · 2019: 38 · 2018: 22 · 2017: 33 · 2016: 42 · 2015: 38 · 2014: 53 · 2013: 54 · 2012: 60
FWCI: 38.64
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Amgen
German-Israeli Foundation for Scientific Research and Development
Canada Research Chairs
Israel Science Foundation
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
Keywords: angiotensin-converting enzyme 2, ACE2, cardiac function, hypertension, quantitative trait loci, X chromosome, cardiac contractility, angiotensin II, hypoxia, Acer, cardiac morphogenesis, rat model, mouse knockout
MeSH terms: Angiotensin II, Animals, Hypoxia, Blood Pressure, Cloning, Molecular, Drosophila melanogaster, Female, Heart, Hypertension, Peptidyl-Dipeptidase A, Male, Metalloendopeptidases, Myocardial Contraction, Myocardium, X Chromosome, Up-Regulation, Gene Expression Regulation, Enzymologic, Gene Deletion, Mice, Knockout, Quantitative Trait, Heritable, Radiation Hybrid Mapping, Drosophila Proteins, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Angiotensin-converting enzyme 2 is an essential regulator of heart function

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks